Skip to Main Content

COVID-19 INFORMATION
Information from TN Dept of Health about the Ongoing Novel Coronavirus Outbreak

Breakthrough Cases

CDC defines a COVID-19 Vaccine Breakthrough Case as a U.S. resident with SARS-CoV-2 RNA or antigen detected on a respiratory specimen collected ≥14 days after completing the primary series of an FDA-authorized COVID-19 vaccine. To learn more about breakthrough cases across the U.S. and how they are being reported to the CDC: https://www.cdc.gov/vaccines/covid-19/health-departments/breakthrough-cases.html